| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.039 | 0.8 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |